Shaping therapeutic trajectories in mental health: Instructive vs. permissive causality.
Antidepressants
Environment
Lifestyle
Major depression
Neural plasticity
Serotonin
Journal
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
ISSN: 1873-7862
Titre abrégé: Eur Neuropsychopharmacol
Pays: Netherlands
ID NLM: 9111390
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
14
02
2020
revised:
05
11
2020
accepted:
02
12
2020
pubmed:
2
1
2021
medline:
18
1
2022
entrez:
1
1
2021
Statut:
ppublish
Résumé
We are currently facing the challenge of improving treatments for psychiatric disorders such as major depression. Notably, antidepressants have an incomplete efficacy, mostly due to our limited knowledge of their action. Here we present a theoretical framework that considers the distinction between instructive and permissive causality, which allows formalizing and disentangling the effects exerted by different therapeutic strategies commonly used in psychiatry. Instructive causality implies that an action determines a specific effect while permissive causality allows an action to take effect or not. We posit that therapeutic strategies able to improve the quality of the living environment or the ability to face it, including changes in lifestyle and psychotherapeutic interventions, rely mainly on instructive causality and thus shape the individual's ability to face the psychopathology and build resilience. By contrast, pharmacological treatments, such as selective serotonin reuptake inhibitors, act primarily through a permissive causality: they boost neural plasticity, i.e. the ability of the brain to change itself, and therefore allow for instructive interventions to produce beneficial effects or not. The combination of an instructive and a permissive action represents the most promising approach since the quality of the living environment can shape the path leading to mental health while drug treatment can increase the likelihood of achieving such a goal.
Identifiants
pubmed: 33384216
pii: S0924-977X(20)30972-X
doi: 10.1016/j.euroneuro.2020.12.001
pii:
doi:
Substances chimiques
Antidepressive Agents
0
Psychotropic Drugs
0
Serotonin Uptake Inhibitors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-9Informations de copyright
Copyright © 2020 Elsevier B.V. and ECNP. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare no competing financial interests. Funders had no role in the preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.